{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigaa76t6uizxs47zm7idmnprhhn6qbp2bzpbxroiolfldkognql6m",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mjltpf44hak2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaoviiwdfzb4u6g3xle2vdr525axkwvmsqbo34jguhd4lm4ucbfp4"
    },
    "mimeType": "image/jpeg",
    "size": 72781
  },
  "path": "/2026/04/15/peptides-fda-panel-to-discuss-broader-access-compounding/?utm_campaign=rss",
  "publishedAt": "2026-04-15T13:30:02.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Breaking News",
    "Health",
    "Politics",
    "chronic disease",
    "FDA",
    "Policy",
    "RFK Jr.",
    "STAT+"
  ],
  "textContent": "The FDA will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufacture certain peptides",
  "title": "STAT+: FDA panel will meet to discuss allowing broader access to certain peptides",
  "updatedAt": "2026-04-15T18:26:34.000Z"
}